Avantor returned to year-over-year organic growth in the third quarter of 2026, reporting net sales of $1.70 billion and adjusted EPS of $0.22. While reported revenue came in below analyst expectations of $1.76 billion, the organic growth rate of 5.2% substantially outperformed the anticipated 2.5%. This strong underlying performance, characterized by accelerating distribution volumes and a return to growth in medtech, prompted management to raise its full-year outlook for organic revenue, earnings, and cash flow.
Key Highlights
- Organic revenue grew 5.2% for the quarter, significantly exceeding the 2.5% growth estimate as end-market demand stabilized.
- Adjusted EPS of $0.22 beat the $0.21 analyst consensus, supported by disciplined execution and higher sales volumes.
- VWR Distribution & Services organic growth accelerated to 5.8%, driven by improving laboratory activity and strategic focus.
- Management raised FY2026 organic revenue guidance to a range of 0.75% to 1.25% (previously -0.5% to +0.5%).
- Free cash flow reached $156.2 million in the quarter, facilitating a reduction in adjusted net leverage to 3.1x.